In the past week, XRAY stock has gone down by -1.82%, with a monthly decline of -1.32% and a quarterly plunge of -1.01%. The volatility ratio for the week is 0.58%, and the volatility levels for the last 30 days are 2.06% for DENTSPLY Sirona Inc The simple moving average for the past 20 days is -1.69% for XRAY’s stock, with a -16.55% simple moving average for the past 200 days.
Is It Worth Investing in DENTSPLY Sirona Inc (NASDAQ: XRAY) Right Now?
The 36-month beta value for XRAY is at 0.96. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 13 as “hold,” and 0 as “sell.”
The public float for XRAY is 197.77M, and currently, shorts hold a 4.52% of that float. The average trading volume for XRAY on June 25, 2025 was 2.91M shares.
XRAY) stock’s latest price update
The stock price of DENTSPLY Sirona Inc (NASDAQ: XRAY) has surged by 2235339 when compared to previous closing price of 15.48, but the company has seen a -1.82% decline in its stock price over the last five trading sessions. accessnewswire.com reported 2025-06-17 that NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/XRAY.
Analysts’ Opinion of XRAY
Many brokerage firms have already submitted their reports for XRAY stocks, with Morgan Stanley repeating the rating for XRAY by listing it as a “Equal-Weight.” The predicted price for XRAY in the upcoming period, according to Morgan Stanley is $14 based on the research report published on April 15, 2025 of the current year 2025.
Wells Fargo gave a rating of “Equal Weight” to XRAY, setting the target price at $20 in the report published on February 14th of the current year.
XRAY Trading at 3.65% from the 50-Day Moving Average
After a stumble in the market that brought XRAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.04% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XRAY starting from LUCIER GREGORY T, who purchase 15,142 shares at the price of $16.51 back on Mar 03 ’25. After this action, LUCIER GREGORY T now owns 81,971 shares of DENTSPLY Sirona Inc, valued at $249,994 using the latest closing price.
Stock Fundamentals for XRAY
Current profitability levels for the company are sitting at:
- -0.22 for the present operating margin
- 0.52 for the gross margin
The net margin for DENTSPLY Sirona Inc stands at -0.24. The total capital return value is set at -0.2. Equity return is now at value -34.47, with -13.79 for asset returns.
Based on DENTSPLY Sirona Inc (XRAY), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at 0.18. The debt to equity ratio resting at 1.21. The interest coverage ratio of the stock is -11.93.
Currently, EBITDA for the company is -532.0 million with net debt to EBITDA at -3.52. When we switch over and look at the enterprise to sales, we see a ratio of 1.38. The receivables turnover for the company is 6.16for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.10.
Conclusion
In conclusion, DENTSPLY Sirona Inc (XRAY) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
